HOME >> MEDICINE >> NEWS
Great (taste) expectations: Study shows brain anticipates taste, shifts gears

As the prism of our senses, the human brain has ways of refracting sensory input in defiance of reality.

This is seen, for example, in the placebo effect, when simple sugar pills or inert salves taken by unwitting subjects are seen to ease pain or have some other beneficial physiological effect. How the brain processes this faked input and prompts the body to respond is largely a mystery of neuroscience.

Now, however, scientists have begun to peel back some of the neurological secrets of this remarkable phenomenon and show how the brain can be rewired in anticipation of sensory input to respond in prescribed ways. Writing in the current issue (March 1, 2006) of the journal Brain, Behavior, and Immunity, a team of University of Wisconsin-Madison scientists reports the results of experiments that portray the brain in action as it is duped.

The new work, conducted by a team led by UW-Madison assistant professor of psychology and psychiatry Jack B. Nitschke, tested the ability of the human brain to mitigate foul taste through a ruse of anticipation. The work, conducted at the UW-Madison Waisman Center using state-of-the-art brain imaging techniques and distasteful concoctions of quinine on a cohort of college students, reveals in detail how the brain responds to a manipulation intended to mitigate an unpleasant experience.

"There is a potent impact to expectancy," says Nitschke, who, with his colleagues, exposed 43 undergraduate subjects to potions of quinine, sugar water or distilled water while undergoing magnetic resonance imaging (MRI).

The subjects, Nitschke explains, were asked beforehand to associate a prescribed set of cues with a taste. A "minus sign" flashed through fiber optic goggles to subjects undergoing MRI, for instance, was to be an anticipatory signal that a liquid subsequently dripped into the mouth would have a very bitter taste. A "zero "cue corresponded with a neutral taste, and a "plus sign" with a pleasant
'"/>

Contact: Jack B. Nitschke
jnitschke@wisc.edu
608-263-6083
University of Wisconsin-Madison
21-Feb-2006


Page: 1 2

Related medicine news :

1. Greater cooperation needed for advancement of stem cell research
2. Greater use of evidence-based medicine needed in US outpatient care
3. Greater risk of death for cardiac surgery patients with long ICU stay
4. Study, meta-analysis examine factors associated with death from heatstroke
5. Study says COPD testing is not measuring up
6. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
7. Study reveals gaps in vaccine financing for underinsured children
8. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
9. Study shows radiofrequency ablation highly effective in treating kidney tumors
10. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
11. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus

Post Your Comments:
(Date:12/22/2014)... (PRWEB) December 22, 2014 The founders ... BLS and ACLS online certification provider, are proud to ... . The updated site now features a more user-friendly ... ever to use. , As a company spokesperson ... is now consolidated into a single page during the ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The holidays are ... of the season. Many may be thinking about how to ... of a few weeks. Health Republic Insurance of New York ... Dietitian, Andrea Chernus, to provide some smart ideas to enjoy ... healthy. , 1)    Avoid arriving at a holiday gathering over-hungry , ...
(Date:12/22/2014)... U.S. and state health officials are investigating a listeria ... least four people and sickened 28 others in 10 ... prepackaged caramel apples until more information becomes available, the ... a news release. As of Dec. 18, a ... outbreak strains of the bacteria Listeria monocytogenes . ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Physicians in ... (rituximab) for the treatment of non-Hodgkin’s lymphoma (NHL), according ... a leading global healthcare consulting firm. MabThera is the ... (DLBCL), the most common form of NHL. , According ... and Barriers,” the incidence of NHL in China has ...
(Date:12/22/2014)... 22, 2014 Super Saturday, the last ... year as the busiest day in the 2014 holiday ... Grass Station had a steady pre-Christmas stream of customers, ... past Saturday. , “I definitely intend to take advantage…of ... Denver resident who was enjoying The Grass Station’s holiday ...
Breaking Medicine News(10 mins):Health News:ACLS Online Certification Website ACLS-PALS-BLS.com Now Features a New and User-Friendly Layout 2Health News:Health Republic Insurance of New York Offers Five Simple Tips to Eat Healthy During the Holidays 2Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2
(Date:12/22/2014)... STOCKHOLM , Dec. 22, 2014 Swedish ... Inc. today announced that the Committee for Medicinal Products ... (EMA) has adopted a positive opinion for the use ... adult men with Peyronie,s disease with a palpable plaque ... the start of therapy. The use of ...
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
(Date:12/22/2014)... 22, 2014  Pfenex Inc. (NYSE MKT: PFNX) today ... has been filed and is now open and that ... Department of Health and Human Services (HHS), through the ... "We are extremely pleased to have the IND now ... a significant milestone in our company,s partnership with BARDA ...
Breaking Medicine Technology:Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Insights into the Marketplace and Individual Market Growth 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 2Pfenex Announces Active IND and Additional BARDA Funding for Recombinant Anthrax Vaccine Program, Px563L 3
Cached News: